Home > Insider Trading > Filing (0001179110-18-009767)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Gtx Inc	GTXI	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1648010	C. Diane Young	175 Toyota Plaza 7Th Floor Memphis TN 38103	Vp, Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-07-13	2,014	$14.92	47,985	No	4	F	Direct
Common Stock	Disposition	2018-07-16	2,049	$14.70	45,936	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Footnotes

Shares withheld by the issuer pursuant to the Rule 16b-3(c) exemption to satisfy tax withholding obligations arising out of the vesting of a portion of previously granted restricted stock units.
Shares sold to satisfy tax withholding obligations arising out of the vesting of a portion of previously granted restricted stock units.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.43 to $14.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
Due to clerical error, the Reporting Person is filing this amendment to correctly indicate the securities were disposed of rather than acquired as was shown in the previous filing on July 17, 2018. The amount of securities beneficially owned following the reported transaction in Table I, Box 5 remains correct.